ranolazine has been researched along with dichloroacetic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, B; McCormack, JG; Wyatt, KM | 1 |
| Abiko, Y; Hara, A; Hashizume, H; Maruyama, K; Matsumura, H | 1 |
| Hill, JA; Schofield, RS | 1 |
| Pauly, DF; Pepine, CJ | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
| César, LA; Gowdak, LH; Mansur, AP | 1 |
| Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M | 1 |
4 review(s) available for ranolazine and dichloroacetic acid
| Article | Year |
|---|---|
Role of metabolically active drugs in the management of ischemic heart disease.
Topics: Acetanilides; Animals; Cardiovascular Agents; Carnitine; Clinical Trials as Topic; Dichloroacetic Acid; Energy Metabolism; Fatty Acids; Glucose; Humans; Insulin; Myocardial Ischemia; Myocardium; Piperazines; Potassium; Ranolazine; Trimetazidine | 2001 |
Ischemic heart disease: metabolic approaches to management.
Topics: Acetanilides; Cardiovascular Agents; Carnitine; Dichloroacetic Acid; Energy Metabolism; Humans; Myocardial Ischemia; Oxidation-Reduction; Piperazines; Ranolazine; Ribose; Trimetazidine | 2004 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease; Dichloroacetic Acid; Humans; Piperazines; Quality of Life; Ranolazine; Ribose; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2009 |
Metabolic support for the heart: complementary therapy for heart failure?
Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine | 2016 |
3 other study(ies) available for ranolazine and dichloroacetic acid
| Article | Year |
|---|---|
Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism.
Topics: Acetanilides; Acetyl Coenzyme A; Animals; Coenzyme A; Dichloroacetic Acid; Heart; Male; Myocardium; Perfusion; Piperazines; Pyruvate Dehydrogenase Complex; Ranolazine; Rats; Rats, Wistar; Reference Values | 1996 |
Protective effects of ranolazine, a novel anti-ischemic drug, on the hydrogen peroxide-induced derangements in isolated, perfused rat heart: comparison with dichloroacetate.
Topics: Acetanilides; Animals; Dichloroacetic Acid; Energy Metabolism; Enzyme Activation; Hydrogen Peroxide; Lipid Peroxidation; Male; Myocardial Ischemia; Piperazines; Pyruvate Dehydrogenase Complex; Ranolazine; Rats; Rats, Sprague-Dawley; Vascular Resistance | 1998 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |